Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary F Lewis

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Annals of Internal Medicine|July 25, 2017
Polygenic Risk for Hypertriglyceridemia Can Mimic a Major Monogenic MutationPriska Stahel, Changting Xiao, Robert A Hegele, et al.
The Lancet. Diabetes & Endocrinology|August 26, 2019
Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practiceAnkit Garg, Vinay Garg, Robert A Hegele, et al.
Diabetes|May 29, 2002
Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humansAndré Carpentier, Bruce W Patterson, Nathalie Leung, et al.
Journal of Multidisciplinary Healthcare|January 4, 2011
Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshopAnna M Sawka, Lilian Magalhães, Amiram Gafni, et al.
Canadian Journal of Diabetes|October 24, 2018
Insulin-Treated Diabetes and Driving: Legal Jeopardy and Consequences of HypoglycemiaIan Blumer, Anne B Kenshole, Jacob Stilman, et al.
The Canadian Journal of Cardiology|February 21, 2018
The Atherogenic Dyslipidemia Complex and Novel Approaches to Cardiovascular Disease Prevention in DiabetesPriska Stahel, Changting Xiao, Robert A Hegele, et al.
Diabetes|June 25, 2015
Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein MetabolismChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2021
GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological RoleAvital Nahmias, Priska Stahel, Lili Tian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 28, 2013
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese menSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Current Opinion in Lipidology|March 8, 2022
Lymphatics - not just a chylomicron conduitMajid M Syed-Abdul, Lili Tian, Changting Xiao, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Annals of Internal Medicine|July 25, 2017
Polygenic Risk for Hypertriglyceridemia Can Mimic a Major Monogenic MutationPriska Stahel, Changting Xiao, Robert A Hegele, et al.
The Lancet. Diabetes & Endocrinology|August 26, 2019
Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practiceAnkit Garg, Vinay Garg, Robert A Hegele, et al.
Diabetes|May 29, 2002
Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humansAndré Carpentier, Bruce W Patterson, Nathalie Leung, et al.
Journal of Multidisciplinary Healthcare|January 4, 2011
Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshopAnna M Sawka, Lilian Magalhães, Amiram Gafni, et al.
Canadian Journal of Diabetes|October 24, 2018
Insulin-Treated Diabetes and Driving: Legal Jeopardy and Consequences of HypoglycemiaIan Blumer, Anne B Kenshole, Jacob Stilman, et al.
The Canadian Journal of Cardiology|February 21, 2018
The Atherogenic Dyslipidemia Complex and Novel Approaches to Cardiovascular Disease Prevention in DiabetesPriska Stahel, Changting Xiao, Robert A Hegele, et al.
Diabetes|June 25, 2015
Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein MetabolismChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2021
GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological RoleAvital Nahmias, Priska Stahel, Lili Tian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 28, 2013
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese menSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Current Opinion in Lipidology|March 8, 2022
Lymphatics - not just a chylomicron conduitMajid M Syed-Abdul, Lili Tian, Changting Xiao, et al.
Pageof 14